| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
long intergenic non-protein coding RNA 1150 | 0.931 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
mitochondrial ribosomal protein S31 | 1.000 | 0.038 | 5.4E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
CFTR intron 2 DNase I hypersensitive site | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
G protein-coupled receptor 146 | 1.000 | 0.038 | 0.15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
leucine rich repeat containing 55 | 1.000 | 0.038 | 3.8E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
protocadherin gamma subfamily A, 4 | 1.000 | 0.038 | 2.2E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
synaptotagmin 5 | 1.000 | 0.038 | 1.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
C2 calcium dependent domain containing 4A | 0.931 | 0.077 | 1.7E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
C2 calcium dependent domain containing 4B | 0.931 | 0.077 | 8.9E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2012 | ||||||||
|
non insulin dependent diabetes mellitus 2 | 0.931 | 0.077 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2011 | |||||||||
|
diabetes mellitus, transient neonatal | 0.890 | 0.077 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2014 | |||||||||
|
recombination signal binding protein for immunoglobulin kappa J region like | 0.931 | 0.077 | 2.9E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
colipase | 0.890 | 0.077 | 9.6E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
RAN pseudogene 1 | 0.931 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | |||||||||
|
T cell receptor beta variable 7-8 | 0.931 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
G protein-coupled receptor 142 | 0.890 | 0.077 | 1.9E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 1550 | 0.931 | 0.077 | 2.7E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
phosphatidylcholine transfer protein | 0.861 | 0.077 | 8.8E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
PDX1 C-terminal inhibiting factor 1 | 0.890 | 0.077 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
major facilitator superfamily domain containing 1 | 0.890 | 0.077 | 3.3E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
solute carrier family 41 member 2 | 0.931 | 0.077 | 0.97 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
early endosome antigen 1 | 0.890 | 0.077 | 0.93 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
CTBP1 divergent transcript | 0.931 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
solute carrier family 16 member 11 | 0.861 | 0.115 | 4.9E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
kinesin family member 28, pseudogene | 0.839 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 |